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INTRODUCTION
Hypocalcemia is one of the most common complications of thy-
roidectomy; the reported incidence of transient hypocalcemia 
ranges from 0.3% to 49%, and that of permanent hypocalcemia 
ranges from 0% to 13% (1). Given the high incidence of tran-
sient hypocalcemia, concerns about postoperative hypocalcemia 
often become a major determinant in delay of early discharge 
(2). Even though close monitoring of serum calcium level is a 
standard of care for the patient who undergoes thyroidectomy 
(3-6), it has limitations as an early predictor of postoperative hy-
pocalcemia, because the lowest concentration of serum calcium 
is usually not reached until 48 hours after thyroidectomy (7). 
  Many recent studies have focused on the search for reliable 
early predictors of postoperative hypocalcemia. Monitoring the 
level of serum total calcium (Ca) or ionized calcium (iCa
++), cal-
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culating slopes in the change of Ca or iCa
++ levels, measuring in-
traoperative or standard intact parathyroid hormone (iPTH) lev-
el, and making a new algorithm by combining more than two of 
these values have all been reported as useful predictors (4, 8-11). 
However, the definitions of hypocalcemia that were used in these 
studies are diverse; therefore, the reported cut-off values of Ca, 
iCa
++, and PTH levels for prediction of hypocalcemia are also 
widely variable. Moreover, some studies focused only on the 
prediction of biochemical hypocalcemia (12, 13); however, in 
practice, observation of a mismatch between the presence of hy-
pocalcemic symptoms and biochemical abnormalities is not un-
common. Therefore, there may be confusion in the interpreta-
tion of these data and limitations in the clinical application of 
previously reported findings.
  In this study, we subdivided the study cohort into four groups 
according to symptomatic and/or biochemical hypocalcemic cri-
teria. Chronological dissociation in the initial presentation of hy-
pocalcemic symptoms and the initial detection of biochemical 
hypocalcemia was evaluated in order to understand the differ-
ent characteristics of symptomatic and biochemical hypocalce-
mia. Predictive values of previously well-known biomarkers were 
compared in each group; Ca and iCa
++, iPTH, and the slopes of 
changes in Ca, iCa
++, and iPTH. A simple new algorithm is pro-
posed for the early and reliable prediction of post-thyroidecto-
my hypocalcemia; for both symptomatic and biochemical hypo-
calcemia.
MATERIALS AND METHODS
We retrospectively reviewed medical records of 123 consecutive 
patients who underwent total thyroidectomy with or without 
neck dissection (ND) and who were hospitalized for more than 
3 days after the surgery between May 2004 and July 2005. At 
that period of time, patients were usually hospitalized for more 
than 3 days after surgery and daily routine follow-up of bioche-
mical markers were performed for screening of possible postop-
erative hypocalcemia. All the surgery was performed by one of 
the authors (YIS). Operation records, progression notes, nursing 
charts, and results of blood tests were noted. This study was ap-
proved by the Institutional Review Board of Samsung Medical 
Center (IRB-2010-05-068-001).
  Because Ca or iCa
++ is known to reach its lowest level on the 
third day after thyroidectomy in hypocalcemic patients (11), Ca 
and iCa
++ levels were measured before surgery (within 2 month 
before surgery), at 1 hour, and every morning for 3 days after 
surgery. Immediate postoperative level was checked at 1 hour 
after surgery at PACU (post-anesthesia care unit). Using an im-
munoradiometric assay (ELSA-PTH, October 2004-model 13, 
Cis bio international, France), blood iPTH (reference value of 
our institution; 11-62 pg/mL) level was checked at 1 hour and 
the next morning after surgery. Slopes of changes in Ca, iCa
++, 
and iPTH levels were calculated using values obtained at 1 hour 
and the next morning after surgery (3). Routine biochemical tests 
were repeated at 3 month after the surgery. If there was an evi-
dence of hypocalcemia, additional laboratory test was performed 
according to the patients’ hypocalcemic status.
  Among 123 patients, 11 patients were excluded from the study 
due to missing one or more of the laboratory tests described abo-
ve. Twenty two male and 90 female patients (total 112 patients) 
were finally enrolled for this study. Their ages ranged from 17 to 
79 years old, with a mean of 51. One hundred seven patients 
were diagnosed as papillary carcinoma, 4 patients as follicular 
carcinoma, and 1 patient as medullary carcinoma. Total thyroid-
ectomy with ND (anterior compartment and/or lateral ND) was 
performed in 70 patients (62.5%). Autotransplantation of para-
thyroid glands was performed in 29 patients (25.9%). Patients’ 
demographic characteristics are summarized at Table 1. 
Table 1. Clinical characteristics of the patients
Variable S-B- group S+B+ group S+B- group S-B+ group P-value
No. of patients (%) 50 (44.6) 45 (40.1) 9 (8.0) 8 (7.1)
Sex (male:female) 10:40 8:37 2:7 2:6 0.979
Median age (years) 50.1 48.0 47.0 57.5 0.123
Histopathology of tumor 
   Papillary carcinoma 48 42 9 8 0.770
   Follicular carcinoma   2   2 - -
   Medullary carcinoma -   1 - -
Size of tumor (cm) 1.95±2.2 1.8±2.4 2.5±2.3 1.4±0.83 0.822
Types of surgery 
   TT  29   7 4 2 0.001
   TT with ACND  15 24 1 2
   TT with ACND and LND   6 14 4 4
Parathyroid autotransplantation    7 15 4 3 0.236
Permanent hypocalcemia    0 2 (1.8% ) 0 0 0.129
S-B-: normocalcemia group; S+B+: symptomatic and biochemical hypocalcemia group; S+B-: only symptomatic hypocalcemia group; S-B+: only biochem-
ical hypocalcemia group; TT: total thyroidectomy; ACND: anterior compartment neck dissection; LND: lateral neck dissection.Kim JH et al.: Symptomatic and Biochemical Hypocalcemia after Thyroid Surgery    97
  Symptomatic hypocalcemia was defined when there was any 
episode of symptoms or signs of hypocalcemia during the hos-
pital stay; perioral numbness, tingling sense or paresthesia of 
hands and/or feet, Chvostek sign, Trousseau sign, muscle cramp, 
or tetany. The patients were asked to report any postoperative 
symptoms and signs of hypocalcemia, which were educated by 
corresponding medical staffs when they admitted to an inpatient 
ward. If they reported their discomfort associated with hypocal-
cemia, an assigned nurse or a doctor determined whether it was 
a real hypocalcemic symptom or non-specific one. When it was 
regarded as a reliable hypocalcemic symptom, it was recorded 
in the nursing chart or in the progression note and those events 
were counted as symptomatic hypocalcemias in this study. Bio-
chemical hypocalcemia was defined when any one of the check-
ed Ca levels dropped below 8.0 mg/dL or when iCa
++ level went 
under 1.05 mmol/L. These values have been used to define post-
thyroidectomy hypocalcemia in much of the literature, although 
they are lower than the reference ranges. In our hospital, refer-
ence value of Ca is in between 8.4 mg/dL and 10.2 mg/dL, and 
that of iCa is in between 1.05 mmol/L and 1.35 mmol/L. Per-
manent hypocalcemia was defined as persistent symptomatic or 
biochemical hypocalcemia for more than 6 months after the sur-
gery. Postoperatively, oral calcium supplements (calcium carbon-
ate 1.5 g per day) were routinely provided for all patients. Pa-
tients who developed symptomatic hypocalcemia were managed 
with additional intravenous calcium gluconate and/or oral vita-
min D supplementation in addition to oral calcium carbonate.
  For comparison of the characteristics of symptomatic vs. bio-
chemical hypocalcemia, patients were categorized into four gro-
ups; patients who presented with both symptomatic and bioche-
mical hypocalcemia (S+B+ group), patients with only symptom-
atic hypocalcemia (S+B- group), patients with only biochemical 
hypocalcemia (S-B+ group), and patients without symptomatic 
or biochemical evidence of hypocalcemia (S-B- group). Occur-
rence and onset timing of biochemical and symptomatic hypo-
calcemia are plotted in Fig. 1. Obtained values (mean±standard 
deviations) of the candidate biomarkers, which included Ca, 
iCa
++, and iPTH levels at 1 hour or 1 day after surgery, and slopes 
of the changes in Ca, iCa
++, and iPTH levels are compared in Ta-
ble 2. Predictive accuracy of these biomarkers in each group are 
summarized in Table 3.
  Statistical analysis was performed using a commercially avail-
able software package (SPSS ver. 13.0; SPSS Inc., Chicago, IL, 
USA). ANOVA test was used when comparing group means or 
frequencies. Chi-square test was used for the analysis of diag-
nostic accuracy of different biomarkers between each group. 
RESULTS
Incidence of hypocalcemia (Table 1)
Transient symptomatic or biochemical hypocalcemia developed 
in 62 patients (62/112, 55.3%) and permanent hypocalcemia in 
2 patients (1.8%). Among the 62 hypocalcemic patients, 45 pa-
tients (45/62, 72.5%) experienced both symptomatic and bio-
chemical abnormalities during the hospital stay; thus, they were 
subgrouped into the S+B+ group. Nine patients (14.5%) met 
the criteria for symptomatic hypocalcemia only (S+B- group), 
while 8 patients (12.9%) showed only biochemical hypocalce-
mia (S-B+ group). 
  Anterior compartment ND was performed in 42 patients. Both 
anterior compartment and lateral ND was performed in 28 pa-
tients (totally 70 patients). Lateral ND was performed as a ther-
apeutic intent in all patients. In contrast, clinical suspicion of an-
terior compartment lymph node metastasis was given in only 
13 patients (31%). In overall, therapeutic ND was performed in 
41 patients and prophylactic ND was performed in 29 patients. 
In a prophylactic ND group (n=29), number of S-B- group was 
10, S+B+ group was 13, S+B- group was 1, S-B+ group was 1 
patient respectively. In a therapeutic ND group (n=41), S-B- gro-
up was 11, S+B+ group was 25, S+B- group was 4, S-B+ group 
was 5 patients respectively. This was not a statistically significant 
difference. 
Fig. 1. Mismatch on the occurrence of symptomatic and biochemical 
hypocalcemia. In 45 patients of the S+B+ group (triangles), 24 pa-
tients presented with symptomatic and biochemical abnormalities 
on the same day (triangles along a dotted line) and the remaining 
21 patients on different days of the hospital stay (scattered trian-
gles). Nine patients presented with only symptomatic hypocalcemia 
(S+B- group, rectangles), while 8 patients revealed only biochemi-
cal hypocalcemia (S-B+ group, circles). 
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Mismatch on the occurrence of symptomatic and biochemical 
hypocalcemia (Fig. 1)
Of 45 patients in the S+B+ group, 24 patients (24/45, 53.3%) 
presented with symptomatic and biochemical abnormalities on 
the same day. A mismatch on the occurrence timing of symp-
tomatic or biochemical hypocalcemia was observed in the other 
21 S+B+ patients (21/45, 46.6%), which corresponded to 33.9% 
of all transient hypocalcemic patients (21/65). There was a 1-day 
gap between the initial occurrence of symptoms/signs and bio-
chemical abnormality in 11 patients (17.7%), a 2-day gap in 8 
patients (12.9%), and a 3-day gap in 2 patients (3.2%).
Comparison of biomarkers in each group (Table 2)
Mean values of Ca and iCa
++ measured at 1 hour after surgery 
in the recovery room were in the range of 8.31-8.68 mg/dL and 
1.10-1.12 mmol/L, respectively, which were all above the hypo-
calcemic criteria in the every group. However, Ca and iCa
++ mea-
sured on the morning after surgery (day 1) showed wide ranges 
across the hypocalcemic criteria. Day 1 iCa
++ level of S-B- pa-
tients (1.11±0.05 mmol/L) was within the reference value and 
was statistically higher than that of S-B+ (1.01±0.05 mmol/L) 
and S+B+ (0.99±0.07 mmol/L) patients, which belonged to the 
criterion for biochemical hypocalcemia (1.05 mmol/L). Slopes 
of changes in Ca or iCa
++ levels were helpful in differentiation of 
the S-B- group and S+B+ group, but not between the other gro-
ups. Standard iPTH levels of the S+B+ and S+B- groups mea-
sured either 1 hour or 1 day after surgery were all statistically 
lower than those of the S-B- group and were below the reported 
useful criterion, 10 pg/mL (14). However, those of the S-B+ group 
were 13.8±9.87 pg/mL and 12.5±10.6 pg/mL, respectively, 
which were not different from those of the S-B- group and above 
the level of 10 pg/mL. None of the patients experienced symp-
Table 2. Comparison of measured parameters (mean±standard deviation) in each group
S-B- (n=50) S+B+ (n=45) S+B- (n=9) S-B+ (n=8) P-value
Total calcium (mg/dL)
   Postop-1H 8.68±0.42
a 8.31±0.58
a 8.72±0.67 8.36±0.74
a <0.05
   Next morning 8.27±0.39
b 7.54±0.44
b, c 8.00±0.39
c 7.95±0.45
b <0.001
c <0.05
Ionized calcium (mmol/L)
  Postop-1H 1.12±0.04 1.10±0.05 1.11±0.05 1.10±0.04 NS
  Day 1 1.11±0.05
d, e 0.99±0.07
d, f 1.06±0.04
f 1.01±0.05
e d, e <0.001
f <0.05
Slope of changes (postop-1H & day 1)
  Total calcium -0.25±0.22
g -0.46±0.34
g -0.50±0.57 -0.28±0.46
g <0.05
  Ionized calcium -0.13±0.67
h -1.44±1.23
h -0.65±0.60 -1.17±0.36
h <0.001
Standard iPTH (pg/mL)
  Postop-1H 20.7±12.7
i, j 4.04±2.82
i 5.62±3.55
j 13.8±9.87
i, j <0.001
  Day 1 20.1±7.78
k, l 4.31±3.23
k 9.22±6.08
l 12.5±10.6
k <0.001
l <0.05
S-B-: normocalcemic group; S+B+: symptomatic and biochemical hypocalcemic group; S+B-: symptomatic hypocalcemic group; S-B+: biochemical hy-
pocalcemic group; Postop-1H: levels measured at 1 hour after surgery; NS: not significant; a to l: each alphabet indicate that the certain P-value was cal-
culated from comparing the corresponding values that have been the same upper-note alphabet. 
Table 3. Predictive abilities (%) of tested parameters in each hypo-
calcemic group
Sensitivity  Specificity  PPV NPV DA
Total calcium (mg/dL) at day 1
   S+B+ 44.4 96.0 90.9 65.8 71.6
   S+B- 22.2 96.0 50.0 87.3 84.7
   S-B+ 0.0 96.0 0.0 85.7 82.8
Ionized calcium (mmol/L) at day 1
   S+B+ 53.3 100.0 100.0 70.4 77.9
   S+B- 0.0 100.0 0.0 84.7 84.7
   S-B+ 62.5 100.0 100.0 94.3 94.8
Slope of changes between 1 hour and 1 day after surgery
   Total calcium
      S+B+ 88.9 24.0 51.3 70.6 54.7
      S+B- 77.8 24.0 15.6 85.7 32.2
      S-B+ 87.5 24.0 15.6 92.3 32.8
   Ionized calcium
      S+B+ 93.3 44.0 60.0 88.0 67.4
      S+B- 88.9 44.0 22.2 95.7 50.8
      S-B+ 100.0 44.0 22.2 100.0 51.7
Standard intact PTH (pg/mL)
   One hour after surgery
      S+B+ 100.0 76.0 78.9 100.0 87.4
      S+B- 100.0 76.0 42.9 100.0 79.7
      S-B+ 50.0 76.0 25.0 90.5 72.4
   Day 1
      S+B+ 81.4 91.1 89.7 83.7 86.4
      S+B- 57.1 83.7 33.3 93.2 80.4
      S-B+ 50.0 83.7 33.3 91.1 78.9
PPV: positive predictive value; NPV: negative predictive value; DA: diagno-
stic accuracy; S+B+: symptomatic and biochemical hypocalcemic group; 
S+B-: symptomatic hypocalcemic group; S-B+: biochemical hypocalce-
mic group; PTH: parathyroid hormone.Kim JH et al.: Symptomatic and Biochemical Hypocalcemia after Thyroid Surgery    99
tomatic hypocalcemia when their postoperative iPTH level was 
higher than 10 pg/mL.
Prediction of postoperative hypocalcemia (Table 3)
Overall diagnostic accuracy of day 1 Ca and iCa
++ levels ranged 
from 71.6% to 84.7% and 77.9% to 94.8%, respectively. Stan-
dard iPTH level measured 1 hour or 1 day after surgery exhibit-
ed diagnostic accuracies ranging between 72.4% and 87.4%. 
However, slopes of changes in Ca or iCa
++ levels showed much 
poorer diagnostic accuracies ranging from 32.2% to 67.4%. In 
the meanwhile, PTH level obtained at one hour after surgery 
and iCa
++ slope obtained at the next morning showed relatively 
higher sensitivity than the other biomarkers.
DISCUSSION
This study demonstrated the heterogeneous nature of symptom-
atic and biochemical hypocalcemia. Among 62 hypocalcemic 
patients, 17 patients (27.4%) exhibited either symptomatic or 
biochemical hypocalcemia. Even though 45 of 62 hypocalcemic 
patients (72.5%) experienced both symptomatic and biochemi-
cal abnormalities during their three-day hospital stay, 21 of these 
patients (33.9%) had mismatches in the timing of initial presen-
tation or occurrence between symptomatic and biochemical hy-
pocalcemia. Therefore, for reliable prediction of postoperative 
hypocalcemia, both symptomatic and biochemical hypocalce-
mic criteria should be considered together. 
  The reason for these mismatches in the timing of initial pre-
sentation or in the occurrence of symptomatic and biochemical 
hypocalcemia is not clear. We speculate that routine postopera-
tive oral calcium supplementation might influence on develop-
ing symptomatic hypocalcemia and/or biochemical hypocalce-
mia. Routine supplementation of oral calcium might obscure an 
early detection of hypocalcemia as well. Velocity of calcium re-
duction also influence on the onset of symptoms of hypocalce-
mia, since hypocalcemic symptoms are usually influenced not 
only by serum total calcium level but also by the velocity of cal-
cium reduction (15). Another possibility is an over-diagnosis of 
symptomatic hypocalcemia in this study since we defined as sym-
ptomatic hypocalcemia if there is any event of tingling sensation 
regardless of its severity. In our study, numbness or tingling sense 
of the lip, hands, or feet was the most common symptom. The 
Chvostek sign was observed only in 5 patients. None of the pa-
tients experienced myalgia, muscle spasm, hypotension, or ab-
normal findings on EKG that were attributable to the low level 
of serum calcium. In most of the cases, postoperative symptom-
atic hypocalcemia was easily controlled with intravenous infu-
sion of calcium gluconate±oral vitamin D administration. 
  Relatively strict criteria for hypocalcemia adopted in this study, 
inclusion criteria of more than 3 days of hospitalization and se-
lection of the patient cohort who received total thryoidectomy±
ND, thus inducing a bias of selecting more patients with compli-
cations, might explain the relatively higher incidence of transient 
hypocalcemia (58%) observed in this study. Also, designated stu-
dy period belongs to an early experience of thyroidectomy of 
the author (YIS). And relatively higher rate of ND is also attrib-
uted to higher incidence of hypocalcemia. Anterior compartment 
ND±lateral ND was performed in 70 of 112 patients (63%) and 
hypocalcemia developed in 51 of these 70 patients (72.8%). Per-
manent hypocalcemia occurred in 2 patients (1.8%) of ND, and 
these two patients belonged to the S+B+ group.
  We performed autotransplantation of the parathyroid gland in 
sternocleidomastoid muscle when discolored tissue was confir-
med as a parathyroid gland by frozen biopsy. One or two para-
thyroid glands was autotransplanted in 29 of 112 patients (25.9%), 
and 22 of them (75.9%) experienced postoperative hypocalce-
mia. As noted before (16), higher incidence of hypocalcemia was 
observed in this patient group of parathyroid autotransplantation 
(Table 1, P=0.016).
  Many studies have focused on the search for reliable early pre-
dictors of postoperative hypocalcemia in the hope of safe early 
discharge after thyroidectomy, including continuous monitoring 
of serum calcium level for at least postoperative 23 hours (16) 
and routine oral calcium supplementation for all patients (17). 
Even though an upward-sloping curve of Ca level is reported to 
be predictive of no occurrence of postoperative hypocalcemia (3, 
18), upward-sloping of Ca or iCa
++ was an infrequent event (14% 
or 21%, respectively) in this study and their diagnostic accura-
cies, specificities, and positive predictive values were relatively 
poor. Because iPTH has a very short half life (less than 5 min-
utes) (19, 20) and a high sensitivity and high specificity ranging 
between 80% to 100%, intraoperative iPTH is currently the most 
emphasized biomarker (11, 12, 14, 21). In this study, iPTH level 
measured at 1 hour after surgery showed high sensitivity and 
high negative predictive value in the S+B+ and S+B- groups. And 
none of the patients experienced symptomatic hypocalcemia 
when postoperative iPTH level was higher than 10 pg/mL. How-
ever, its ability for prediction of the S-B+ group widely ranged 
from 25.0% to 90.5%. Therefore, measurement of iPTH alone 
will not be sufficient for safe and reliable prediction of heteroge-
neous types of postoperative hypocalcemia. 
  Given that 1) none of the patients was symptomatic when post-
operative iPTH level was higher than 10 pg/mL, 2) postopera-
tive iPTH level was a useful biomarker in differentiation of nor-
mocalcemic patients from S+B- or S+B+ patients with high di-
agnostic accuracies, and 3) day 1 iCa
++ level was also useful in 
differentiation of normocalcemia from hypocalcemia of S-B+ or 
S+B+ patients with the highest diagnostic accuracy, we propose 
a relatively simple guideline for an early and reliable prediction 
of postoperative hypocalcemia by combining iPTH level and 
day 1 iCa
++ levels. When iPTH level measured about 1 hour af-
ter surgery is equal to or higher than 10 pg/mL, none of the pa-
tients will develop symptomatic hypocalcemia; therefore, early 100    Clinical and Experimental Otorhinolaryngology   Vol. 4, No. 2: 95-100, June 2011
discharge can be considered for them. If iPTH level is lower than 
10 pg/mL, discharge should be decided according to the level of 
iCa
++ measured at next morning after the surgery. When iCa
++ 
level is less than 1.05 mmol/L, more attention including careful 
observation with calcium supplementation is highly recommend-
ed. 
  In summary, we retrospectively demonstrated that symptom-
atic and biochemical hypocalcemia after thyroidectomy may dif-
fer in their occurrence and onset timing. Therefore, for the safety 
of patients, the possibility of both symptomatic and biochemical 
hypocalcemia should be considered together before deciding an 
early discharge from the hospital. Intact PTH level checked at 1 
hour after surgery was useful in prediction of symptomatic hy-
pocalcemia. Serum ionized calcium measured on the morning 
after surgery was a reliable predictor for biochemical hypocalce-
mia. Using both iPTH and postoperative iCa
++ levels will increase 
the diagnostic accuracy for the early and reliable prediction of 
postoperative hypocalcemia.
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